ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery bleeding study tests best drug dose
Disease control Recruiting nowThis study compares three different doses of the drug tranexamic acid in 150 adults having elective heart surgery with a heart-lung machine. The goal is to find which dose best controls bleeding and reduces the need for blood transfusions. Researchers will measure how long the dr…
Matched conditions: ADVERSE DRUG EVENT
Phase: NA • Sponsor: University of Ioannina • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
Sleep hormone may shield kidneys from antibiotic harm
Prevention Recruiting nowThis study tests whether melatonin, a common sleep aid, can prevent kidney damage in hospitalized patients who need a strong antibiotic called vancomycin. About 300 adults aged 18 to 75 will receive either melatonin or a placebo alongside their antibiotic. The goal is to see if m…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE3 • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
New sedative could keep ICU patients calmer on ventilators
Symptom relief Recruiting nowThis study tests whether remimazolam besylate works as well as dexmedetomidine for keeping patients lightly sedated while on a breathing machine after non-cardiac surgery. About 306 adults aged 18–64 will take part across five hospitals in China. The goal is to see if remimazolam…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE4 • Sponsor: Beijing Shijitan Hospital, Capital Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Gene study aims to predict chemo side effects in kids with leukemia
Knowledge-focused Recruiting nowThis study is observing 500 Indian children with acute lymphoblastic leukemia (ALL) to see how their genes influence treatment side effects and how well they respond to therapy. Researchers will track side effects and measure early response to steroids. The goal is to better unde…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC